NCT06645444 Immediate Implant Placement With Different Materials of Customized Healing Abutment for Guiding Peri-implant Soft Tissue Healing in Posterior Teeth
| NCT ID | NCT06645444 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Peri-implant Mucositis |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2025-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-06-01 with a primary completion date of 2025-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
: Immediate Implant Placement with different materials of customized healing abutment for guiding Peri-implant Soft Tissue Healing in Posterior Teeth: A Randomized controlled clinical trial.
Eligibility Criteria
Inclusion Criteria: * Inclusion Criteria of participants: * Periodontally and systemic healthy patients * Patients aged \> 18 years * Non- restored teeth for many reasons (i.e. endodontic failure, unworthy for treatment in deep caries/non-caries lesion and root fracture), locate in the posterior area in the maxillary or mandibular arch indicate for customized implant with no need for additional bone and soft tissue augmentation procedures. * An adequate vertical bone for immediate implant placement. * Implants will be positioned with adequate primary stability so that transmucosal healing can be accomplished. * No taken medications known to interfere healing or periodontal tissue health or bone metabolism. * No previous periodontal surgery at involved sites. * Good oral hygiene and good compliance with the plaque control instructions following initial therapy. Exclusion criteria: * Patients with active periodontal diseases (bleeding on probing- probing depth \> 4 mm) or those under orthodontic treatment. * Poor oral hygiene (full mouth plaque score \> 25% and full mouth bleeding score \> 25%) * Smoking habits (\> 10 cigarettes/day) * Severe acute or chronic periodontitis * Severe bruxism habits * History of oral/IV bisphosphonates taking * Remote or recent radiation therapy in the oro-maxillo-facial area or recent chemotherapy. * Xerostomia * Pregnant and lactating mothers * Patients who have been received periodontal surgery in the study area during the last year. * Clinical or radiographic signs of periapical pathology contraindicating immediate implant placement. * Implants showing signs of peri-implant mucositis and peri-implantitis during the study period will be excluded from the following analyses.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06645444 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Peri-implant Mucositis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06645444 currently recruiting?
Yes, NCT06645444 is actively recruiting participants. Contact the research team at marwa.helal@dentistry.cu.edu.eg for enrollment information.
Where is the NCT06645444 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06645444 clinical trial?
NCT06645444 is sponsored by Cairo University. The trial plans to enroll 20 participants.